Scott Juda - 21 Mar 2022 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Director
Signature
/s/ Scott Juda
Issuer symbol
INMB
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 16:29:41 UTC
Previous filing
17 Nov 2021
Next filing
21 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +35,000 $0.000000 35,000 21 Mar 2022 Common Stock 35,000 $7.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.